The 21-gene Recurrence Score assay from PMID18360352Sig21 (Oncotype DX Breast Cancer Assay) is prognostic for women treated with tamoxifen with lymph node-negative and ER+ breast cancer [2,30]. Here, ESR1 is linked to breast carcinoma.